133 related articles for article (PubMed ID: 18271679)
1. Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma.
Bílek R; Šafařík L; Ciprová V; Vlcek P; Lisá L
Physiol Res; 2008; 57 Suppl 1():S171-S179. PubMed ID: 18271679
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Václavíková E; Widimský J
Physiol Res; 2017 Sep; 66(Suppl 3):S397-S408. PubMed ID: 28948824
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A (CgA) in adrenal tumours.
Glinicki P; Jeske W; Bednarek-Papierska L; Kasperlik-Załuska A; Rosłonowska E; Gietka-Czernel M; Zgliczyński W
Endokrynol Pol; 2013; 64(5):358-62. PubMed ID: 24186592
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.
Ramachandran R; Bech P; Murphy KG; Caplin ME; Patel M; Vohra S; Khan MS; Dhillo WS; Sharma R; Palazzo FF; Win Z; Tan T; Khoo B; Meeran K; Frilling A; Ghatei MA; Bloom SR; Martin NM
J Clin Endocrinol Metab; 2015 Apr; 100(4):1520-8. PubMed ID: 25664601
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
Giovanella L; Squin N; Ghelfo A; Ceriani L
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
[TBL] [Abstract][Full Text] [Related]
6. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
7. [Chromogranin A and neuroendocrine tumors].
Díaz Pérez JÁ; Currás Freixes M
Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
[TBL] [Abstract][Full Text] [Related]
8. High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma.
Cotesta D; Caliumi C; Alò P; Petramala L; Reale MG; Masciangelo R; Signore A; Cianci R; D'Erasmo E; Letizia C
Tumori; 2005; 91(1):53-8. PubMed ID: 15850005
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy inpatients with adrenal incidentalomas.
Giovanella L; Ceriani L; Balerna M; Keller F; Taborelli M; Marone C; Ferone D
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):84-88. PubMed ID: 17538521
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A assay in clinical practice.
d'Herbomez M; Do Cao C; Vezzosi D; Borzon-Chasot F; Baudin E;
Ann Endocrinol (Paris); 2010 Sep; 71(4):274-80. PubMed ID: 20538257
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
12. High permanent plasma adrenaline levels: a marker of adrenal medullary disease in medullary thyroid carcinoma.
Vistelle R; Grulet H; Gibold C; Chaufour-Higel B; Delemer B; Fay R; Delisle MJ; Caron J
Clin Endocrinol (Oxf); 1991 Feb; 34(2):133-8. PubMed ID: 1673649
[TBL] [Abstract][Full Text] [Related]
13. Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.
Giovanella L; Ceriani L
Int J Biol Markers; 2002; 17(2):130-4. PubMed ID: 12113580
[TBL] [Abstract][Full Text] [Related]
14. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
Rao F; Keiser HR; O'Connor DT
Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
[TBL] [Abstract][Full Text] [Related]
15. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
d'Herbomez M; Gouze V; Huglo D; Nocaudie M; Pattou F; Proye C; Wémeau JL; Marchandise X
J Nucl Med; 2001 Jul; 42(7):993-7. PubMed ID: 11438617
[TBL] [Abstract][Full Text] [Related]
17. The role of chromogranin A in the management of patients with phaeochromocytoma.
Grossrubatscher E; Dalino P; Vignati F; Gambacorta M; Pugliese R; Boniardi M; Rossetti O; Marocchi A; Bertuzzi M; Loli P
Clin Endocrinol (Oxf); 2006 Sep; 65(3):287-93. PubMed ID: 16918946
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A as a diagnostic marker of pheochromocytoma and paraganglioma: A systematic review and meta-analysis.
Xing Y; Shi H; Guo Q; Wang C; Li C; Hao C
Int J Urol; 2024 Jun; 31(6):637-645. PubMed ID: 38380475
[TBL] [Abstract][Full Text] [Related]
19. Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines.
Miehle K; Kratzsch J; Lenders JW; Kluge R; Paschke R; Koch CA
J Endocrinol Invest; 2005 Dec; 28(11):1040-2. PubMed ID: 16483187
[No Abstract] [Full Text] [Related]
20. Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males.
Glinicki P; Jeske W; Kapuścińska R; Zgliczyński W
Endokrynol Pol; 2015; 66(1):53-6. PubMed ID: 25754282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
